In this issue:
- Effects of semaglutide on CKD in type 2 diabetes
- Semaglutide and kidney outcomes by KDIGO risk category in SUSTAIN 6
- Effects of pantoprazole on kidney outcomes
- Genomic testing in kidney failure of an unknown cause
- Updated thiazide diuretic evidence for kidney stone recommendations
- Prognostication after dialysis withdrawal
- Aldosterone synthase inhibition ± empagliflozin for CKD
- Hypertension and kidney function after kidney donation
- Association of IBD with IgA nephropathy
- Implications of TKI pharmacology for kidney diseases
Please login below to download this issue (PDF)